← Leaderboards
Zhiguo Li
University Of Kentucky
$1,749,738
Attributed
$1,749,738
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $445.2K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,749,738 · 1
By mechanism
R01$1,749,738 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Natasha Kyprianou$5,760,730
- Ka-Wing Fong$792,948
- William H St Clair$3,066,919
- Michal J. Toborek$37,025,871
- Vivek M Rangnekar$11,055,380
Others in their field
Other Rising Stars on “Enterobacteria Phage P1 Cre Recombinase”
- Joshua D. Wythe · Baylor College Of Medicine$2,673,001
- Robert Nathaniel Helsley · University Of Kentucky$2,651,504
- Megan K Ruhland · Oregon Health & Science University$2,265,578
- Sam Kurup · University Of Georgia$1,887,500
- Alberto Cruz-Martin · Boston University (Charles River Campus)$1,569,000
- Grinu Mathew · University Of Nebraska Medical Center$1,379,946
Research focus
Enterobacteria Phage P1 Cre RecombinaseAdvanced Prostate CancerEffective TherapyDesignAndrogensAnti-Pd-L1 TherapyAndrogen Deprivation TherapyAutophagocytosisAllelesBiometryBreedingCancer CellCancer EtiologyCancer PatientApoptosisCell GrowthCellsCell SurvivalCellular BiologyCessation Of LifeClinicClinical ResearchComparative EfficacyFostering
Grant awards (4)
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy$445,226
R01 · FY2025 · CA · contact PI
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy$422,964
R01 · FY2024 · CA · contact PI
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy$436,322
R01 · FY2023 · CA · contact PI
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy$445,226
R01 · FY2022 · CA · contact PI